16/01/2026 - Press release
Researchers from the Hospital del Mar Research Institute and the Vall d'Hebron Institute of Oncology have demonstrated, in animal models, the role played by these cells in the development of cancer cells. The study, published in Science Advances, shows that eliminating these cells at an early stage of tumor growth promotes tumor proliferation and the formation of metastases. By contrast, combining their elimination with an inhibitor of the CCL2 molecule reduces tumor size and eliminates metastases.
13/01/2026 - General information
The journal Nature Mental Health has published a landmark scientific article on the prevention of depression and suicidal behaviour through an evidence-based programme designed to reduce depression and suicidal behaviour: the 4-Level Community Intervention, developed by the European Alliance Against Depression (EAAD). The EAAD approach offers a sustainable model of community-based mental health care that can be effectively adapted to a wide range of contexts, including current and future public health emergencies.
29/12/2025 - General information
A clinical trial led by a team from the Hospital del Mar Research Institute, in collaboration with Hospital de la Santa Creu i Sant Pau, has received nearly €1.3 million in funding from Spain's Carlos III Health Institute (ISCIII), under the 2025 call of the Strategic Action in Health-Strategic Lines of Health Research. It is one of the 14 clinical trials selected. The trial is led by Dr. Ana Aldea, coordinator of the HMRIB Clinical Research Unit and Head of the Clinical Pharmacology Section at Hospital del Mar, and Dr. Rafael de la Torre, coordinator of the Integrated Pharmacology and Systems Neuroscience Research Group at the Hospital del Mar Research Institute.
29/12/2025 - Institutional news
Hospital del Mar Research Institute (HMRIB) has secured a Singulars grant from the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), co-funded by the European Regional Development Fund (ERDF) and the Government of Catalonia, to carry out the project "Development of Advanced and Emerging Therapies at the Hospital del Mar Research Institute". With a total eligible budget of €1.67 million, the project will be implemented between 2026 and 2028 and aims to transform and modernise the Institute's research infrastructure to consolidate its leadership in the development and validation of advanced therapies, particularly in areas such as cell therapies, RNA-based therapies and immunotherapy.
24/12/2025 - General information
23/12/2025 - General information
The Joan Oró grants aim to fund the recruitment of predoctoral researchers in training who pursue their PhD studies within the Catalan university system. These grants help promote the training and research activities of the recruited researchers and increase their qualifications and professional development during the early stages of their research careers, thereby strengthening the generation of cutting-edge knowledge and its transfer.
18/12/2025 - General information
The study published last April in PNAS by the team led by Dr Pilar Navarro, coordinator of the Cancer Molecular Targets Research Group at the Hospital del Mar Research Institute and the IIBB-CSIC-IDIBAPS, has been selected by Nature as one of the ‘Six highlights from pancreatic cancer research’ of 2025.
16/12/2025 - Press release
It aims to develop the first treatment based on mRNA therapy to boost the efficacy of immunotherapy for this type of tumour. The new company, a spin-off of the Hospital del Mar Research Institute Barcelona, plans to launch its first human clinical trial in 2028 to validate the safety of this approach. The project is led by Drs. Toni Celià-Terrassa and Joan Albanell, pioneers in the development of nanotherapies designed to transform tumours that are resistant to immunotherapy into tumours that are vulnerable to treatment.
16/12/2025 - Press release
These are some of the conclusions of the report "Working on digital platforms: What do we know about health and safety?", a joint study by UPF and the Hospital del Mar Research Institute Barcelona, within the framework of the international project GIG-OSH, which has collected data from seven European countries.
15/12/2025 - Institutional news
In compliance with the Spanish Law DA 17.2(c) of Organic Law 3/2018 on the reuse of biomedical research data, participants of the studies listed below are informed that their pseudonymised data will be reused in the REDAMCOR Project ("Genomics of heart failure of different aetiology in 3,600 cases and 36,000 controls - REDAMCOR Project" - PI24-00035), approved by the Research Ethics Committee on Medicinal Products (CEIm) of Parc de Salut Mar, Barcelona, under number 2024/11683/I, and funded by the Health Research Fund of the Instituto de Salud Carlos III (PI24-00035). Participants are asked to read carefully the information sheet available at the link provided. If you do not agree to your data being used for this medical research, you may notify the responsible investigator, Dr. Jaume Marrugat, at [email protected], by post at C/Doctor Aiguader 88, 08003 Barcelona, or by phone at 933160800.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
